These big stocks are teetering on the edge of breakdown territory.
Flexion is an arthritis-focused biotech company.
Insys Therapeutics, Ultragenyx Pharmaceutical and Alexion Pharmaceuticals were among the biotech stock movers in premarket trading on Thursday.
Valeant shares were down nearly 2% at one point on news that it has completed several refinancing transactions.
In the first quarter of the year we've seen some high-profile IPOs. But they're not all created equal. Here's what investors should keep an eye out for ... and avoid.
It has been a wild ride thus far, and we've only completed one round of action.
Also on the move were Global Blood Therapeutics, Valeant and Kite Pharma, among others.
Esperion Therapeutics, Minerva Neurosciences and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.